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Objectives The purpose of this study was to examine use and describe outcomes of radial access for percutaneous coro-
nary intervention (PCI) in patients with ST-segment elevation myocardial infarction (STEMI).
Background Transradial PCI (TRI) is associated with reduced risk of bleeding and vascular complications, as compared with
femoral access PCI (FPCI). Studies have suggested that TRI may reduce mortality among patients with STEMI.
Methods We examined 294,769 patients undergoing PCI for STEMI at 1,204 hospitals in the CathPCI Registry between
2007 and 2011. Patients were grouped according to access site used for PCI. The temporal trend in the rate of
radial versus femoral approach was determined. For minimization of confounding, an inverse probability weight-
ing analysis incorporating propensity scores was used to compare procedural success, post-PCI bleeding, door-to-
balloon times, and in-hospital mortality between radial and femoral access.
Results Over the 5-year period, the use of TRI versus FPCI in STEMI increased from 0.9% to 6.4% (p  0.0001). There
was no difference in procedural success. TRI was associated with longer median door-to-balloon time (78 vs. 74
min; p  0.0001) but lower adjusted risk of bleeding (odds ratio [OR]: 0.62; 95% CI: 0.53 to 0.72; p  0.0001)
and lower adjusted risk of in-hospital mortality (OR: 0.76; 95% CI: 0.57 to 0.99; p  0.0455).
Conclusions In this large national database, use of radial access for PCI in STEMI increased over the study period. Despite
longer door-to-balloon times, the radial approach was associated with lower bleeding rate and reduced in-
hospital mortality. These data provide support to execute an adequately powered randomized controlled trial
comparing radial and femoral approaches for PCI in STEMI. (J Am Coll Cardiol 2013;61:420–6) © 2013 by the
American College of Cardiology Foundation
ublished by Elsevier Inc. http://dx.doi.org/10.1016/j.jacc.2012.10.032S
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STreatment of acute ST-segment elevation myocardial in-
farction (STEMI) has improved substantially, and the
mortality rates from this condition have continued to
decline (1). Despite these positive trends, bleeding rates
emain high, particularly in the setting of primary or rescue
ercutaneous coronary intervention (PCI) (2,3). In this
context, strategies that reduce bleeding risk appear to be
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tudies have indicated that a large proportion of bleeding
mong patients with STEMI undergoing primary PCI was
elated to the vascular access site (5). Outside of the setting
f acute STEMI, transradial PCI (TRI) has been shown in
any studies to reduce post-procedural bleeding and major
ascular complications (6–8). Because there is a learning
urve and subsequently increased procedure duration asso-
iated with TRI (9), the radial approach for primary PCI
ay worsen outcomes due to the clinical importance of
apid reperfusion. On the other hand, the lower rate of
dverse outcomes associated with TRI has the potential to
mprove outcomes in high-risk patients such as those with
TEMI. Studies that have examined these issues have
eported conflicting results. Small single-center studies have
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January 29, 2013:420–6 Radial Access in STEMI PCIshown that door-to-balloon times with a radial approach are
similar to those with the femoral approach. A larger meta-
analysis of randomized and observational studies showed that
TRI was associated with longer procedural times (10,11).
Similarly, studies have conflicted in reporting bleeding and
mortality outcomes associated with vascular access sites (radial
vs. femoral). Some studies have shown lower rates, whereas 2
randomized trials have different conclusions. In the STEMI
subgroup of the RIVAL (Radial vs Femoral Access for
Coronary Intervention Trial) study, there was no difference in
major bleeding between the radial and femoral groups, but
there was an association between TRI and reduced 30-day
mortality (12). In contrast, 2 meta-analyses have shown a
reduction in bleeding and mortality with transradial primary
PCI (11,13).
The National Cardiovascular Data Registry (NCDR) is
the largest ongoing contemporary database of PCI proce-
dures, which provides an ideal opportunity to explore the
prevalence and in-hospital outcomes of TRI in STEMI.
Accordingly, we examined the temporal trends of TRI in
STEMI, compared patient and hospital characteristics by
access site, and evaluated the association between TRI for
STEMI and in-hospital outcomes.
Methods
Data source and study sample. The NCDR CathPCI
Registry is an initiative of the American College of Cardi-
ology (ACC) Foundation and the Society for Cardiovascu-
lar Angiography and Interventions. Descriptions of the
NCDR and CathPCI Registry have been previously pub-
lished (14–15). Demographic, clinical, procedural, and
institutional data elements from diagnostic catheterization
and PCI procedures were collected at more than 1,315
participating centers. Data were entered via either a secure
Web-based platform or software provided by ACC-certified
vendors. Data quality assurance included automatic system
validation and reporting of data completeness, random
on-site auditing of participating centers, and education and
training for site data managers (16). All data elements and
definitions were prospectively defined by a committee of the
ACC. A comprehensive description of NCDR data ele-
ments and definitions is available at http://www.ncdr.com/
webncdr/cathpci/home/datacollection.
The study population consisted of patients with STEMI
treated with immediate primary PCI or rescue PCI from
January 1, 2007, to September 30, 2011. Patients were
excluded if they had cardiogenic shock, more than 1 PCI
during hospitalization, PCI through access of a nonfemoral
and nonradial artery (i.e., ulnar, brachial), or unknown data
on bleeding events. After these exclusions (Fig. 1), 294,769
patients from 1,204 sites were included in the analysis of
prevalence and temporal trends of TRI for STEMI. For
comparison of patient and hospital characteristics by ap-
proach (radial vs. femoral) and determination of the asso-
ciation between TRI for STEMI and in-hospital outcomes,further exclusions were made.
Patients with sufficient data to
calculate in-hospital mortality
and bleeding risk according to
CathPCI Registry version 4
models, from sites with at least 1
radial PCI for STEMI, were in-
cluded for analysis, resulting in a
final study population of 90,879
patients from 541 sites.
Endpoints and definitions. The
primary endpoint for this analy-
sis was in-hospital mortality.
Other endpoints were procedural
success (defined as the number of lesions dilated divided by
the number of lesions attempted) and bleeding. Bleeding
was defined as the presence of 1 or more of the following
within 72 h of PCI: overt access site bleeding, retroperito-
neal hemorrhage, intracranial hemorrhage, gastrointestinal
or genitourinary bleeding, cardiac tamponade, non–bypass
surgery–related blood transfusion in patients with a pre-
procedure hemoglobin 8 g/dl, or an absolute decrease in
hemoglobin3 g/dl from pre- to post-PCI in patients with
a pre-procedure hemoglobin value 16 g/dl.
Abbreviations
and Acronyms
FPCI  facilitated
percutaneous coronary
intervention
PCI  percutaneous
coronary intervention
STEMI  ST-segment
elevation myocardial
infarction
TRI  transradial
percutaneous coronary
intervention
Figure 1 The CONSORT Diagram
Patient population from CathPCI Registry selected for the study, displayed as a
CONSORT diagram. The population was initially selected to allow analysis of
prevalence and temporal trends of transradial percutaneous coronary interven-
tion (TRI) for ST-segment elevation myocardial infarction (STEMI). For compari-
son of patient and hospital characteristics by approach (radial vs. femoral) and
determination of the association between TRI for STEMI and in-hospital out-
comes, further exclusions were made. PCI  percutaneous coronary
intervention.
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Duke University Medical Center institutional review board
and was determined to meet the definition of research not
requiring informed consent.
Statistical analysis. For determination of the temporal
trends in the use of TRI for STEMI over the study period
from 2007 to 2011, the quarterly proportion of TRI cases
out of all PCI cases for STEMI (radial plus femoral) was
calculated.
Patient and hospital characteristics were compared by
approach (radial vs. femoral and overall). Patient character-
istics, including demographics, history and risk factors,
coronary anatomy, PCI procedure, lesions and devices,
laboratory values, intraprocedure and post-procedure events,
discharge, and hospital characteristics, were compared. Cat-
egorical variables are presented as frequencies (percentages),
and differences between the 2 groups were assessed using
Figure 2 Balance of Continuous and Categorical Variables Afte
Pre- and post-inverse probability of treatment weighting (IPW) balance of the covar
all variables. Continuous variables were reasonably balanced even before IPW (all
filtration rate; HF  heart failure; Hgb  hemoglobin; NYHA  New York Heart Assthe chi-square test when the sample size was sufficient,
otherwise using an exact test. Continuous variables are
presented as median (Q1, Q3) and were compared using the
Wilcoxon rank-sum test.
For the development of a propensity score model for TRI
versus femoral PCI, a logistic regression model was fit-
adjusted for patient characteristics before catheterization.
Variables were selected a priori from the CathPCI Registry
version 4 in-hospital mortality and bleeding models to
include variables that were related to the outcomes (17).
Specifically, sex, age, body mass index, cerebrovascular
disease, peripheral vascular disease, chronic lung disease,
prior PCI, diabetes, ejection fraction, renal failure (glomer-
ular filtration rate 30 or dialysis), glomerular filtration
rate, cardiogenic shock, PCI status (emergency/salvage vs.
urgent), New York Heart Association heart failure class,
cardiac arrest, and pre-procedure hemoglobin (as a contin-
ustment
etween radial and femoral patients was checked. IPW improved the balance for
0.004). (A) Continuous variables. (B) Categorical variables. GFR  glomerular
n; other abbreviation as in Figure 1.r Adj
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January 29, 2013:420–6 Radial Access in STEMI PCIuous linear spline with 1 knot at 13) were included in the
propensity score model. The overlap of the distributions of
propensity scores by radial and femoral patients was assessed
by looking at histograms of propensity scores and descrip-
tive statistics. Pre- and post-inverse probability of treatment
weighting (IPTW) balance of the covariates between radial
and femoral patients was checked (18,19).
For determination of the association between TRI and
in-hospital outcomes, logistic regression with generalized
estimating equations was used to account for within-
hospital clustering. Propensity score was developed and used
to adjust for confounding by the IPTW method. For
maximization of efficiency, weights were stabilized by using
the marginal probability of TRI (20,21). For radial patients,
weights were calculated by dividing the marginal probability
of radial by the individual patient’s propensity score, and
weights for femoral patients were calculated by dividing (1
minus the marginal probability of radial) by (1 minus the
individual patient’s propensity score). A limitation of this
method is that one cannot adjust for unmeasured confound-
ing. Along with the adjusted odds ratio (OR), the number
needed to treat (NNT) is presented with 95% CIs, esti-
mated from 200 bootstrap samples.
Propensity score model. The adequacy of the propensity
score model was assessed by checking the distribution of
propensity scores by treatment for reasonable overlap and
the pre- and post-IPTW balance of the covariates. Percen-
tiles of propensity scores were similar between femoral (first 
0.033, 50th 0.063, 99th 0.151) and radial patients (first
Demographic and Clinical Characteristicsof the Study Population (N  90,879)Table 1 Demographic and Clinical Characteristicsof the Study Population (N  90,879)
Variable
Radial
(N  6,159)
Femoral
(N  84,720) p Value
Mean age, yrs 59.37 12.51 60.61 12.95 0.0001
Male 75.27 72.38 0.0001
White 89.24 88.09 0.0074
Body mass index, kg/m2 30.11 6.88 29.12 6.04 0.0001
Previous MI 16.97 19.70 0.0001
Diabetes 22.83 22.81 0.9833
Cerebrovascular disease 6.90 6.77 0.6848
Peripheral vascular disease 6.95 5.69 0.0001
Chronic lung disease 9.34 9.44 0.7761
Hypertension 64.56 65.62 0.0914
Current/recent smoker 45.30 43.93 0.0379
Dyslipidemia 61.81 63.45 0.0096
Family history of CAD 25.05 20.73 0.0001
Previous PCI 17.92 21.19 0.0001
Previous CABG 1.93 5.87 0.0001
Currently on dialysis 0.54 0.89 0.0035
Heart failure within 2 weeks 6.59 5.97 0.0491
Values are mean  SD or %. p Values are based on Pearson chi-square tests for all categorical
ariables and on chi-square rank-based group means score statistics for all continuous/ordinal
ariables. p  0.05 indicates that the summary measures (i.e., medians for continuous variables
nd proportions for categorical variables) differ significantly between the radial and femoral access
roups.
CABG  coronary artery bypass graft; CAD  coronary artery disease; MI  myocardial
nfarction; PCI  percutaneous coronary intervention.0.037, 50th  0.067, 99th  0.173). Pre- and post-IPTW tbalance of the covariates between treatment groups was
assessed using Cramer’s phi for categorical variables and R2
for continuous variables. Values closer to zero indicated
better balance. After IPTW adjustment, the r2 measure for
each continuous variable was 0.0001, and it was 0.004
for each categorical variable, which indicates reasonable
balance (Fig. 2).
Results
Population characteristics and treatment. Among 90,879
patients undergoing immediate primary or rescue PCI for
STEMI, 6,159 patients (6.8%) received TRI, whereas
84,720 patients (93.2%) received facilitated PCI (FPCI).
Baseline demographic and clinical history characteristics
(Table 1) were different between the TRI and FPCI groups.
hose undergoing TRI were younger and heavier and were
ore likely to be male, be white, have peripheral vascular
isease, and have recent heart failure; they were less likely to
ave prior MI, PCI, and coronary artery bypass graft, or be
n hemodialysis.
Procedural characteristics were different between the TRI
nd FPCI groups (Table 2). Fluoroscopy time was longer
ith TRI, but the volume of contrast used was less com-
ared with FPCI. Intra-aortic balloon pump insertion was
ore frequent in patients receiving FPCI; however, there
as no difference in the use of PCI without stenting
etween the groups. There was no difference in the use of
rug-eluting stents. Both bivalirudin and glycoprotein IIb/
IIa inhibitors were used more frequently in the FPCI
roup. There was no difference in the frequency of bifurca-
ion lesion treatment, lesion length, or location between the
roups. ACC/American Heart Association high/C lesion
isk was encountered less frequently in patients with TRI
63.99% vs. 66.08%; p  0.0007), but there was no
ifference in the procedural success rate. Median door-to-
Procedural Characteristics in Patients WithSTEMI T eated With Radial and F moral Access PCITable 2 Procedural Characteristics in Patients WithSTEMI Treated With Radial and Femoral Access PCI
Variable
Radial
(N  6,159)
Femoral
(N  84,720) p Value
Fluoroscopy time, min 12.80 10.40 0.0001
Contrast volume, ml 180.00 185.00 0.0001
Left heart catheterization 85.87 85.17 0.5367
IABP 1.69 5.21 0.0001
Drug-eluting stent 51.97 52.46 0.0699
No stent used 9.09 9.80 0.0699
Bivalirudin 30.00 34.65 0.0001
Low-molecular-weight heparin 7.85 5.83 0.0001
Glycoprotein IIb/IIIa (any) 58.14 61.09 0.0001
High/C lesion risk 63.99 66.08 0.0007
Bifurcation lesion 12.71 12.37 0.4254
Single lesion treated 80.55 78.90 0.0542
Lesion successfully dilated 94.82 94.04 0.0254
Door-to-device time, min 78.00 74.00 0.0001
Values are %.
IABP  intra-aortic balloon pump; STEMI  ST-elevation myocardial infarction; other abbrevia-
ion as in Table 1.
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(74 vs. 78 min; p  0.0001).
Temporal trends in the use of TRI. Use of TRI in
STEMI increased over the study period, from 0.9% of
patients receiving TRI in the first quarter of 2007 to 6.4% of
patients receiving TRI in the third quarter of 2011 (p 
0.0001) (Fig. 3).
Association between TRI for STEMI and in-hospital
outcomes. Vascular complications requiring procedural
are were less common in TRI patients compared with
PCI patients (0.13% vs. 0.49%; p  0.001). TRI was
ssociated with in-hospital outcomes (Fig. 4). There was no
ifference in procedural success. Unadjusted rates of bleed-
ng and in-hospital mortality were lower with TRI. After
PTW multivariable adjustment, TRI was associated with
ower risk of bleeding (OR: 0.62; 95% CI: 0.53 to 0.72) and
ower risk of in-hospital mortality (OR: 0.76; 95% CI: 0.57
o 0.99). NCDR version 4–defined bleeding was lower in
he TRI group, as compared with the FPCI group: 6.88%
ersus 11.59% (p  0.0001). NNT to prevent 1 bleeding
vent with TRI was 25; NNT to prevent 1 death with TRI
as 207. The proportion of TRI use in patients with
TEMI among the hospital sites varied from 0.2% to 76.6%
median 2.7%) (Fig. 5).
iscussion
sing data from a broadly representative contemporary PCI
egistry, we reported several important observations. First,
lthough the rate of adoption of radial access for emergent
CI in the United States is low, there is a trend of its
ncreased use from 0.9% to 6.4% in the course of 5 years.
Figure 3 Temporal Trend in Use of TRI for STEMI PCI from 200
Time line in quarters is presented on the x-axis, and use of radial access (%) is precond, we found that radial access was associated withlightly longer door-to-device time compared with femoral
ccess. Third, despite this longer time, there was an asso-
iation between TRI and reduced in-hospital mortality in
atients with STEMI undergoing PCI. Fourth, there was
lso a significant association with reduced bleeding in the
RI group.
Primary reperfusion with PCI is a well-established stan-
ard of care in patients with STEMI (1). Although
atheter-based therapy offers better outcomes compared
2011
d on the y-axis. Abbreviations as in Figure 1.
Figure 4 In-Hospital Outcomes of TRI in STEMI
Association between radial versus femoral access PCI and in-hospital out-
comes, displayed as the relative risk between groups (solid diamonds) with
95% CIs (horizontal lines). Abbreviations as in Figure 1.7 to
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January 29, 2013:420–6 Radial Access in STEMI PCIwith thrombolytic therapy (22), bleeding and other arteri-
otomy site complications are potential limiting factors.
Indeed, studies have indicated that the rate of bleeding was
higher among patients undergoing primary PCI for STEMI
compared with those undergoing PCI for other indications
(4,23). A large proportion of these bleeding events were
related to the vascular access site (5). In this high-risk
population, strategies that reduce bleeding, such as use of
bivalirudin, were associated with reduced mortality (4).
ecause radial access substantially reduces access site bleed-
ng compared with femoral access, its use during primary
nd rescue PCI is of great interest.
Prior trials have examined the association between TRI
nd outcomes among patients with STEMI (11,24). In
ggregate, these studies have shown a reduction in mortal-
ty, but not bleeding, with either slightly reduced door-to-
alloon times (13) or longer procedure times. Based on
hese studies, the explanation for the mortality reduction
ith transradial primary PCI remains elusive. On the other
and, observational studies have consistently shown an
ssociation between TRI and both reduced bleeding and
ortality. An observational study by Chase et al. (25)
howed that the reduction in 1-year mortality among
atients undergoing TRI was largely explained by a reduc-
ion in the need for post-procedure transfusion after trans-
adial procedures. Recently, the RIFLE STEACS (Radial
ersus Femoral Randomized Investigation in ST-Elevation
cute Coronary Syndrome) randomized trial confirmed
hese findings by showing a reduction in 30-day mortality
ith transradial primary PCI of similar magnitude to the
eduction in Bleeding Academic Research Consortium type
2 bleeding. Our study corroborated these studies and
Figure 5 Frequency of TRI Use
Distribution of frequency in radial access use during STEMI PCI by 541 hospital
sites contributing to the National Cardiovascular Data Registry. The percent of
radial access is on the x-axis, and the number of hospitals is on the y-axis.
Abbreviations as in Figure 1.xtends them by examining a large contemporary multicenter iegistry of PCI. Importantly, our study was able to account for
urrent antithrombotic strategies such as bivalirudin.
Overall, there was no difference in procedural success
etween the FPCI and TRI cases, but TRI was associated
ith slightly longer door-to-device time. Shorter door-to-
alloon times have been linked to improved survival (26). In
his context, ambulance and hospital systems participating
n acute infarct angioplasty function under significant time
ressure, with publicly reported quality metrics. Any strat-
gy that delays acute reperfusion requires careful consider-
tion. Concerns about the difficulty with radial access,
avigation of the tortuous arm vasculature to engage the
oronary arteries, and inability to use larger thrombectomy
atheters may be potential reasons why radial access is as
are in clinical practice as documented by our study. The
ssociation between TRI and reduced mortality despite
onger door-to-device time may be reflective of competing
isks—the risk associated with major bleeding after STEMI
CI may be greater than that conferred by a 4-min increase
n reperfusion time. Other factors, such as immediate ability
o ambulate and reduce stress afforded by TRI, may play a
ole, but they were not examined.
tudy limitations. Some limitations of our study should be
onsidered. As with any other observational study, associa-
ions between treatments and outcomes cannot prove cau-
ality. A limitation of the adjustment methodology is that
here is always a chance of unmeasured confounding. There
ight be residual factors that are not known or not captured
y the registry that may bias the results in favor of the
emoral or radial access. However, operators and hospital
ystems in the United States are much more familiar with
emoral access (as reflected by the longer fluoroscopy times
n the TRI group), and any advantage of the radial access
hown by providers early in the learning curve would likely
ecome more evident with more experience in radial pro-
edures. Finally, bleeding events can be underreported.
lthough an auditing program was used to verify data
ccuracy in the registry, outcomes were not adjudicated;
hus, there may be underreporting of complications other
han mortality. It is likely that the associations between
adial access and reduced bleeding would be greater with
igher reported bleeding rates.
onclusions
here was a trend of increased use of radial access for
TEMI PCI from 0.9% to 6.4% in the course of 5 years,
etween 2007 and 2011. Compared with femoral access, use
f radial access for STEMI PCI was associated with slightly
onger door-to-device time and fluoroscopy times but re-
uced bleeding and in-hospital mortality. These data sug-
est that wider adoption of TRI for STEMI may signifi-
antly improve outcomes; however, these results should be
onfirmed in an adequately powered prospective random-
zed trial.
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